Phenytoin (pulverized powder), mefenamic acid (capsule), and sulpiride (ˆlm-coated tablet) are currently available on the Japanese market. For absorption of these drugs from their pharmaceutical preparations, they must disintegrate and dissolve during passage through the gastrointestinal tract. The bioavailability of these drugs diŠer among diŠerent pharmaceutical preparations and even for the same preparation. This led to a review of the in‰uence of the features of pharmaceutical preparations and the physicochemical properties ofˆlm coating materials as well as the physiologic factors aŠecting drug bioavailability. The in‰uence of coadministered drugs and concomitant intake of beverages and food on the bioavailability of drugs from pharmaceutical preparations is also described.
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Vol. 123 (2003) a) Theˆgures indicate means±SD of four subjects. b) Treatment 1: one 250-mg mefenamic acid capsule administered with 50 ml of water to a fasting subject. c) Treatment 2: one 250-mg mefenamic acid capsule administered with 200 ml of water to a fasting subject. d) Treatment 3: one 250-mg mefenamic acid capsule administered with 500 ml of water to a fasting subject. e) Treatment 4: one 250-mg mefenamic acid capsule administered with 50 ml) of water following ingestion of a standard meal.
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Vol. 123 (2003) 食下でヒトに投与した結果，AUC は 2.72 から 9.36 Theˆgures indicate means±S.D. of four subjects. a) A commercially available injection solution containing 25 mg of sulpiride/ml was employed as a reference product. b) Cumulative urinary excretion of sulpiride over 48 h. c) Underlined treatments are not signiˆcantly diŠerent from each other ( p＜0.05) (Tukey's test). d) The peak excretion rate. e) The time to reach the peak excretion rate. f ) Not signiˆcant at the 0.05 level. g) Mean residence time. a) MDTˆlm＝MRTˆlm-coated-MRTuncoated, where MRTˆlm-coated is the mean residence time up to 48 h after oral administration ofˆlm-coated tablet of product A (AEAˆlm-coated tablet), MRTuncoated is the mean residence time up to 48 h after oral administration of uncoated tablet of product A (AEAˆlm-coated tablet). b) Cumulative urinary excretion of sulpiride over 48 h. 
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